Tag Archives: MCC

Top Casino Stocks To Invest In Right Now

Investors can be forgiven for thinking they hit the trifecta last Friday.

The U.S. Bureau of Labor Statistics reported that unemployment had dropped to 3.9%, the lowest in almost 20 years.

The Federal Reserve Bank of Atlanta reported that its widely followed GDP forecasting tool was showing projected growth for the second quarter of 2018 at 4%, exactly where Trump boosters like Larry Kudlow said it would be.

Finally, the Dow Jones industrial average rallied 332 points (1.39%), partly in response to the other good news. It was almost enough to make a trader sing, “Happy days are here again.”

Or not.

The fact is that this good news hides more than it reveals. A look behind the numbers discloses a sobering outlook for investors.

Let’s start with the employment report. The U.S. Department of Labor, Bureau of Labor Statistics report dated May 4, 2018, showed the official U.S. unemployment rate for April 2018 at 3.9%, with a separate unemployment rate for adult men of 4.1% and adult women of 3.7%.

Top Casino Stocks To Invest In Right Now: Minerva Neurosciences, Inc(NERV)

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases. Leveraging our scientific insights and clinical experience, we have acquired or in-licensed four development-stage proprietary compounds that we believe have innovative mechanisms of action and therapeutic profiles that can potentially address the unmet needs of patients with these diseases.
Our product portfolio and potential indications include: MIN-101 for the treatment of schizophrenia; MIN-202 (also known as JNJ-42847922), which we are co-developing with Janssen Pharmaceutica NV, or Janssen, for the treatment of insomnia disorder and adjunctive major depressive disorder, or MDD; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson’s disease.   Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Minerva Neurosciences Inc  (NASDAQ:NERV)Q4 2018 Earnings Conference CallMarch 12, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    AnaptysBio (NASDAQ: NERV) and Minerva Neurosciences (NASDAQ:NERV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

  • [By Max Byerly]

    Minerva Neurosciences (NASDAQ:NERV) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

    Nuvectra (NASDAQ:NVTR) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

  • [By Lisa Levin] Gainers
    Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 92.1 percent to $7.01.
    iPic Entertainment Inc. (NASDAQ: IPIC) gained 21.6 percent to $9.73.
    Baozun Inc. (NASDAQ: BZUN) shares jumped 18.7 percent to $53.49 after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) shares jumped 15.9 percent to $50.50. The company's “Smackdown Live” may not be renewed at NBCUniversal network and the company's “Monday Night Raw” program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.
    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 14.7 percent to $ 20.46 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) climbed 13.4 percent to $5.5009.
    Endocyte, Inc. (NASDAQ: ECYT) rose 13.3 percent to $ 14.23 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting.
    Diana Containerships Inc. (NASDAQ: DCIX) gained 12.9 percent to $1.7499 after the company announced the sale of Post-Panamax Container Vessel for $21 million.
    Essendant Inc. (NASDAQ: ESND) gained 12.7 percent to $12.43. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash.
    Blink Charging Co (NASDAQ: BLNK) rose 11.8 percent to $8.04 after surging 31.68 percent on Wednesday.
    OptimumBank Holdings, Inc. (NASDAQ: OPHC) gained 11.5 percent to $5.15.
    Flotek Industries, Inc. (NYSE: FTK) shares climbed 10.7 percent to $3.74.
    Farmer Bros. Co. (NASDAQ: FARM) rose 7.9 percent to $25.95 after climbing 7.90 percent on Wednesday.
    Minerva Neurosciences Inc (NASDAQ: NERV) rose 6.5 percent to $6.93 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients.
    Williams Partners L.P. (NYSE: WPZ) rose 5.6 percent to $40

Top Casino Stocks To Invest In Right Now: Henry Schein, Inc.(HSIC)

We believe we are the world’s largest provider of health care products and services primarily to office-based dental, animal health and medical practitioners. We serve more than 1 million customers worldwide including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics. We believe that we have a strong brand identity due to our more than 83 years of experience distributing health care products.   Advisors’ Opinion:

  • [By Michael A. Robinson]

    And in late February, General Electric Co. (NYSE:GE) completed the $2.9 billion spin-off of its transportation unit. Just three weeks before that, medical distributor Henry Schein Inc. (Nasdaq: HSIC) shed its animal health business and completed a merger to create Covetrus Inc. (Nasdaq:CVET) in a deal valued at up to $1.2 billion.

  • [By Stephan Byrd]

    TRADEMARK VIOLATION WARNING: “2,495 Shares in Henry Schein, Inc. (HSIC) Acquired by AGF Investments Inc.” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at www.tickerreport.com/banking-finance/4188612/2495-shares-in-henry-schein-inc-hsic-acquired-by-agf-investments-inc.html.

  • [By Motley Fool Transcribers]

    Henry Schein Inc  (NASDAQ:HSIC)Q4 2018 Earnings Conference CallFeb. 20, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Henry Schein (HSIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Casino Stocks To Invest In Right Now: Accuray Incorporated(ARAY)

Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company offers the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation typically with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Accuray (ARAY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Shares of Accuray Incorporated (NASDAQ:ARAY) shot up 5.1% during trading on Friday . The stock traded as high as $4.15 and last traded at $4.10. 2,319,305 shares changed hands during mid-day trading, an increase of 254% from the average session volume of 655,530 shares. The stock had previously closed at $3.90.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Accuray (ARAY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Casino Stocks To Invest In Right Now: Medley Capital Corporation(MCC)

Medley Capital Corporation, incorporated on April 23, 2010, is a non-diversified closed-end management investment company. The Company’s investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions. The Company’s investment portfolio consists of senior secured first lien loans and senior secured second lien loans. Its investment portfolio also includes unitranche loans, senior secured notes, subordinated notes and warrants, and minority equity securities. The Company may invest all of its assets in securities acquired directly from issuers in privately negotiated transactions.

The Company invests in business services, manufacturing, consumer products, healthcare, software, transportation, energy services, real estate and specialty finance sector. MCC Advisors LLC is the Company’s investment adviser.

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Medley Capital Corp (NYSE:MCC) have earned an average recommendation of “Hold” from the six research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation and four have assigned a hold recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $4.67.

  • [By Logan Wallace]

    Moving Cloud Coin (CURRENCY:MCC) traded down 11% against the U.S. dollar during the one day period ending at 20:00 PM E.T. on September 10th. Moving Cloud Coin has a market capitalization of $0.00 and $1.70 million worth of Moving Cloud Coin was traded on exchanges in the last 24 hours. Over the last seven days, Moving Cloud Coin has traded 18% lower against the U.S. dollar. One Moving Cloud Coin coin can now be bought for $0.0189 or 0.00000300 BTC on popular cryptocurrency exchanges including DOBI trade, BCEX and CoinEgg.

  • [By Max Byerly]

    Shares of Medley Capital Corp (NYSE:MCC) have been given a consensus rating of “Hold” by the six analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $4.67.

Top Casino Stocks To Invest In Right Now: Keryx Biopharmaceuticals, Inc.(KERX)

Keryx Biopharmaceuticals, Inc., incorporated on October 22, 1998, is a biopharmaceutical company. The Company is focused on the development of products for the treatment of renal diseases. The Company’s product Auryxia (ferric citrate), also known as Riona in Japan and Fexeric in Europe, is an oral, absorbable iron-based compound, which is indicated for the control of serum phosphorus levels in patients with chronic kidney disease (CKD), on dialysis. The Company operates through the products segment. Auryxia can bind to phosphate in the gastrointestinal tract and form non-absorbable complexes to reduce intestinal absorption and aid in the management of hyperphosphatemia in patients with CKD. The adverse events for Auryxia treated patients were gastrointestinal-related, including diarrhea, nausea, constipation, vomiting and cough.

The Company focuses on Keryx Patient Plus program to assist with patient accessibility to Auryxia. The Keryx Patient Plus program offers benefit verification, co-pay assistance for eligible commercial patients, a no-cost drug program for those who qualify, and a short-term prescription bridge program that may assist those already on Auryxia who are in danger of suffering a lapse in coverage. The approval of Auryxia was based on data from its Phase III registration program, in which Auryxia effectively reduced serum phosphorus levels to well within the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines range of 3.5 to 5.5 milligrams per deciliter. In addition to the effects on serum phosphorus levels, Auryxia’s pharmacodynamic properties resulted in increased ferritin, iron and transferrin saturation (TSAT), whereas these parameters remained relatively constant in patients treated with active control (Renvela and/or PhosLo).

The Company competes with Sanofi, Fresenius Medical Care and Shire Pharmaceuticals Group plc.

Advisors’ Opinion:

  • [By Shane Hupp]

    ILLEGAL ACTIVITY WARNING: “Bank of New York Mellon Corp Sells 69,607 Shares of Keryx Biopharmaceuticals (KERX)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at www.tickerreport.com/banking-finance/4158332/bank-of-new-york-mellon-corp-sells-69607-shares-of-keryx-biopharmaceuticals-kerx.html.

  • [By Logan Wallace]

    Keryx Biopharmaceuticals (NASDAQ:KERX) has been assigned an average rating of “Hold” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $6.00.

Top Casino Stocks To Invest In Right Now: Archrock, Inc.(AROC)

Archrock, Inc., formerly Exterran Holdings, Inc., incorporated on February 2, 2007, is a natural gas contract operations services company. The Company also provides natural gas compression services to customers in the oil and natural gas industry throughout the United States and supplies aftermarket services to customers that own compression equipment in the United States. The Company’s segments include contract operations and aftermarket services. The contract operations segment primarily provides natural gas compression services to meet specific customer requirements. The aftermarket services segment provides a range of services to support the compression needs of customers, from parts sales and normal maintenance services to full operation of a customer’s owned assets.

Contract Operations Services

The Company provides contract operations services, including the personnel, equipment, tools, materials and supplies to meet customers’ natural gas compression needs. Its services include designing, sourcing, owning, installing, operating, servicing, repairing and maintaining equipment to provide these services to its customers. The Company utilizes both slow and high speed reciprocating compressors primarily driven by internal natural gas fired combustion engines. It also utilizes rotary screw compressors for specialized applications. The Company maintains field service locations, from which it can service and overhaul its own compressor fleet to provide contract operations services to its customers.

The Company also has equity interest in Archrock Partners, L.P. (the Partnership), a master limited partnership that provides natural gas contract operations services to customers throughout the United States. The Partnership’s fleet includes over 6,500 of natural gas compressor units comprising approximately 3.3 million horsepower. The Partnership’s fleet also consists of over 50 compressor units, comprising approximately 17,000 horsepower.

Aftermarket Ser! vices

The Company’s aftermarket services segment sells parts and components, and provides operation, maintenance, overhaul and reconfiguration services to customers having compression and oilfield power generation equipment. The Company has operating personnel with access to a range of its compression services and facilities.

Advisors’ Opinion:

  • [By ]

    As it happens, I am familiar with about half of these stocks. Archrock (Nasdaq: AROC), Qualcomm (Nasdaq: QCOM), Schlumberger (NYSE: SLB, and Trinity Industries (NYSE: TRN) are all interesting names that I’ve either owned in the past or have written about recently over at High-Yield Investing.

  • [By Ethan Ryder]

    Archrock (NYSE:AROC) posted its quarterly earnings data on Tuesday. The energy company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02, Briefing.com reports. The firm had revenue of $233.20 million during the quarter, compared to analysts’ expectations of $232.15 million. Archrock had a net margin of 6.32% and a return on equity of 2.49%. The business’s revenue was up 11.6% compared to the same quarter last year.